title: Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study.
abstract: The incidence of hip fractures in Turkey increased markedly from that reported in 1988/1989 so that FRAX® models for Turkey should be revised.
  
  
  BACKGROUND
  The MEDOS study in 1988/1989 reported that men and women from Turkey had exceptionally low rates of hip fracture. The aim of the FRACTURK study was to estimate current and future hip fracture risks and the prevalence of osteoporosis in Turkey.
  
  
  METHODS
  Hip fracture cases in 2009 were identified from interviews of a population-based sample of 26,424 residents aged 50 years or more in 12 different regions of Turkey and in two hospital surveys. Bone mineral density was evaluated by DXA in an age-stratified sample of 1,965 men and women.
  
  
  RESULTS
  Hip fracture incidence in the community-based survey was similar to that in the hospital survey. The age-specific incidence in men and women was substantially higher than that reported for 1988/1989. At the age of 50 years, the remaining lifetime probability of a hip fracture was 3.5% in men and 14.6% in women. In 2009, there were approximately 24,000 hip fractures estimated in Turkey, 73% of which were found in women. Assuming no change in the age- and sex-specific incidence, the number of hip fractures was expected to increase to nearly 64,000 in 2035. The prevalence of osteoporosis at the femoral neck was 7.5% and 33.3% in men and women, respectively, aged 50 years or more.
  
  
  CONCLUSIONS
  Although Turkey is still among the countries with low hip fracture rates in Europe, the incidence has increased markedly in the last 20 years. This finding can be used to recalibrate fracture risk assessment models for Turkey.
authors: Physical Medicine and Rehabilitation Department, Cerrahpaşa School of Medicine, Istanbul University, Istanbul, Turkey. sansintuzun@gmail.com
authors: S
authors: S
authors: Tuzun
authors: N
authors: N
authors: Eskiyurt
authors: U
authors: U
authors: Akarirmak
authors: M
authors: M
authors: Saridogan
authors: M
authors: M
authors: Senocak
authors: H
authors: H
authors: Johansson
authors: J A
authors: JA
authors: Kanis
references: Osteoporos Int. 1997;7(5):407-13
references: 9425497
references: Lancet. 2002 May 18;359(9319):1761-7
references: 12049882
references: Osteoporos Int. 2011 May;22(5):1277-88
references: 21461721
references: Bone. 2000 Nov;27(5):585-90
references: 11062343
references: Osteoporos Int. 1999;9(3):242-53
references: 10450414
references: Osteoporos Int. 1998;8(5):468-89
references: 9850356
references: Osteoporos Int. 2008 Apr;19(4):385-97
references: 18292978
references: Osteoporos Int. 2002;13(2):113-8
references: 11905521
references: J Bone Miner Res. 2002 Jul;17(7):1237-44
references: 12096837
references: Lancet. 1999 Mar 6;353(9155):769-70
references: 10459954
references: Osteoporos Int. 2001;12(6):438-44
references: 11446558
references: Diabetes Care. 2002 Sep;25(9):1551-6
references: 12196426
references: Osteoporos Int. 1996;6(1):69-75
references: 8845603
references: Osteoporos Int. 2009 Aug;20(8):1363-7
references: 19009330
references: J Clin Densitom. 2007 Jul-Sep;10(3):285-8
references: 17574464
references: Osteoporos Int. 2005 Dec;16(12):2025-30
references: 16133641
references: Bone. 2008 Mar;42(3):467-75
references: 18180210
references: Osteoporos Int. 1997;7(4):331-7
references: 9373566
references: Osteoporos Int. 1997;7(6):503-13
references: 9604045
references: Osteoporos Int. 1992 Nov;2(6):298-302
references: 1421798
references: Osteoporos Int. 1994 Sep;4(5):253-63
references: 7812073
references: J Epidemiol Community Health. 2002 Jun;56(6):466-70
references: 12011207